Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. FNCH.NASDAQ

Finch Therapeutics Group Inc (FNCH NASDAQ) stock market data APIs

$1.32 -0.53(-28.6%) as of July 25, 2024
Price chart is built with Anychart

Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524 for the prevention, diagnosis, theragnosis or treatment of diseases in humans, including ulcerative colitis; FIN-525 for the treatment of Crohn's disease; and other microbiome product candidates. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; and license agreements with Skysong Innovations LLC, OpenBiome, Arizona State University, and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Boston, Massachusetts.

Finch Therapeutics Group Inc Financial Data Overview

1.85
1.32
-
1.95
1.32
0.8-8.3485
2 971 K
1 606 K
0
-2.4138
0.408
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'FNCH',
Type: 'Common Stock',
Name: 'Finch Therapeutics Group Inc',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00Q3DQDY6',
ISIN: NULL,
CUSIP: NULL,
CIK: '1733257',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-03-19',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Finch Therapeutics Group Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -22 464 000
  • Earnings Per Share -9.81
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Finch Therapeutics Group Inc Earnings via APIs

  • Latest Release 2024-05-13
  • EPS/Forecast NaN

Get Finch Therapeutics Group Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Finch Therapeutics Group Inc latest news via APIs

Billionaire Seth Klarman’s Biotech Stock Picks

In this article, we discuss billionaire Seth Klarman’s biotech stock picks. To skip the detailed analysis of the biotech industry, Seth Klarman’s investment philosophy, and Baupost Group’s perfo...

Finch Announces Reverse Stock Split of Common Stock

BOSTON, June 09, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch”, “Finch Therapeutics” or the “Company”) (Nasdaq: FNCH), a microbiome technology company with a portfolio...
  • CHANGES IN COMPANY'S OWN SHARES
  • FINCH
  • FINCH THERAPEUTICS GROUP
  • INC
  • MICROBIOME
  • NASDAQ:FNCH
Do you have any questions?
support@eodhistoricaldata.com